 |
|
|
|
|
Utah Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
Recursion Pharmaceuticals, LLC
| | | | | Phone: | (385) 269-0203 | | Fax: | (385) 489-0164 | | Year Established: | 2013 | | Main Contact: | Cristopher C. Gibson, Ph.D., Co-Founder & CEO | | | | Other Contacts: | Martin Brenner, CSO
Blake Borgeson, Co-Founder & CTO
| | | | Company Description | | Recursion Pharmaceuticals is a drug discovery company. Recursion uses a novel drug screening platform to efficiently repurpose and reposition drugs to treat rare genetic diseases. Recursion’s novel drug screening platform combines experimental biology and bioinformatics in a massively parallel system to quickly and efficiently identify treatments for multiple rare genetic diseases. The core of the approach revolves around high-throughput automated screening using high-content assays in human cells, which allows the near simultaneous modeling of hundreds of genetic diseases. Rich data from these assays is probed using advanced statistical and machine learning approaches, and the effects of thousands of known drugs and shelved drug candidates can be investigated efficiently to identify those holding the most promise for the treatment of any one rare genetic disease. | |
|
|
|
|
|
|
|
